Contrast Enhanced Voiding Urosonography with Urodynamic Testing ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
118Myelomeningocele1

118. Myelomeningocele


Clinical trials : 10 Drugs : 18 - (DrugBank : 7) / Drug target genes : 8 - Drug target pathways : 12
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04738539
(ClinicalTrials.gov)
March 2, 20211/2/2021Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic StudiesEfficacy of Contrast Enhanced Voiding Urosonography for Urodynamic StudiesMyelomeningocele;Neurogenic Bladder;Tethered Cord Syndrome;Bladder, Neurogenic;Urologic Diseases;Neurologic DysfunctionDrug: Contrast Enhanced Voiding Urosonography with Urodynamic Testing;Diagnostic Test: Urodynamic TestingUniversity of VirginiaNULLRecruitingN/A18 YearsAll105United States